Diagnosis and treatment of chronic inducible urticaria

Abstract

Dr Weller reports personal fees from Dr R. Pfleger, personal fees from UCB, personal fees from Uriach, personal fees from Moxie, personal fees from Novartis, outside the submitted work. Prof. Magerl reports personal fees from Moxie and personal fees from Novartis, outside the submitted work. Prof. Maurer reports grants and personal fees from Allakos, personal fees from Aralez, personal fees from Alnylam, grants from AstraZeneca, grants and personal fees from BioCryst, grants from Blueprint, personal fees from CSL Behring, grants and personal fees from FAES, grants and personal fees from Genentech, personal fees from Kalvista, grants and personal fees from Menarini, grants from Leo Pharma, grants and personal fees from Moxie, grants and personal fees from MSD, grants from Pharming, personal fees from Pharvaris, grants and personal fees from Roche, grants and personal fees from Sanofi, grants and personal fees from Shire/Takeda, grants and personal fees from UCB, grants and personal fees from Uriach, outside the submitted work. Dr Metz reports personal fees from Moxie, personal fees from Novartis, personal fees from Sanofi, outside the submitted work. Dr Siebenhaar reports personal fees from Novartis, personal fees from Allakos, nonfinancial support from Moxie GmbH, during the conduct of the study. Dr Terhorst-Molawi has nothing to disclose. Dr Hawro has nothing to disclose. Dr Krause reports personal fees from Novartis, personal fees from Moxie, outside the submitted work. Dr Zuberbier reports personal fees from Astra Zeneca, personal fees from AbbVie, personal fees from ALK, personal fees from Almirall, personal fees from Astellas, personal fees from Bayer Health Care, personal fees from Bencard, personal fees from Berlin Chemie, personal fees from FAES, personal fees from HAL, personal fees from Leti, personal fees from MEDA, personal fees from Menarini, personal fees from Merck, personal fees from MSD, grants and personal fees from Novartis, personal fees from Pfizer, personal fees from Sanofi, personal fees from Stallergenes, personal fees from Takeda, personal fees from Teva, personal fees from UCB, grants from Henkel, personal fees from Kryolan, personal fees from L'Oreal, outside the submitted work; and Organizational Affiliations: Committee member, WHO-Initiative “Allergic Rhinitis and its Impact on Asthma” (ARIA)Ðember of the Board, German Society for Allergy and Clinical Immunology (DGAKI)Ðead, European Centre for Allergy Research Foundation (ECARF)Ðecretary General, Global Allergy and Asthma European Network (GA2LEN)Ðember, Committee on Allergy Diagnosis and Molecular Allergology, World Allergy Organization (WAO). Dr Altrichter reports personal fees from Moxie GmbH, other from Allakos, Inc, outside the submitted work.